The European Society of Cardiology Congress 2019 (ESC Congress 2019) provided many important randomized trials in the field of cardiovascular medicine. Several of the trials spanned areas where collaboration between surgeons and cardiologists continues to grow in the form of heart teams, namely structural heart disease and coronary revascularization. No clinical trial is perfect, and interpretation of trial findings and their implications for patient management can often vary significantly. Ultimately, through the discussion of trial findings and their impact, we force ourselves to think critically about how we interpret data and ultimately better refine questions for future analyses. As such, members of the American College of Cardiology's Surgeon's Council have selected four trials from ESC Congress 2019 with relevance to surgeons and cardiologists and provide perspective on the research findings. Four articles, written by Surgeon's Council members who are leaders in their respective fields, are listed below. These articles provide unique perspectives on timely topics that will continue to rely on collaboration across specialties for success and growth.

• A Tale of Two Studies: Are We Closing in on Rational Therapy for Secondary MR?
  by Jock N. McCullough, MD, FACC
• Should the 10-Year Results From the SYNTAX Trial Redefine Who We Consider for CABG?
  by Alexander Iribarne, MD, MS, FACC
• Secondary Prevention After CABG and Long-Term Mortality: Perspectives From the SWEDEHEART Registry
  by Divyanshu Mohananey, MD, MSc, and Harish Ramakrishna, MD, FACC
• Prognostic Implications of Moderate AS: Insights from the National Echocardiography Database Australia
  by Divyanshu Mohananey, MD, MSc, and Harish Ramakrishna, MD, FACC

Keywords: ESC Congress, esc 2019, ESC 19, Cardiac Surgical Procedures, Adrenergic beta-Antagonists, Acute Coronary Syndrome, American Heart Association, Angiotensin-Converting Enzyme Inhibitors, Angiotensin Receptor Antagonists, Aortic Valve, Aortic Valve Stenosis, Aspirin, Atrial Fibrillation, Australia, Cohort Studies, Cardiac Rehabilitation, Comorbidity, Confidence Intervals, Coronary Artery Bypass, Coronary Artery Disease, Diabetes Mellitus, Dilatation, Dyslipidemias, Drug Prescriptions, Echocardiography, Electronic Health Records, Diet, Follow-Up Studies, Heart Failure, Heart Diseases, Heart Valve Prosthesis, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Heart Ventricles, Hospitalization, Hypertension, Hypotension, Incidence, Life Style, Long-Term Care, Mitral Valve, Mitral Valve Insufficiency, Myocardial Infarction, Nutritionists, Odds Ratio, Office Visits, Outcome Assessment, Health Care, Papillary Muscles, Percutaneous Coronary Intervention, Pharmacists, Physical Therapists, Physicians, Primary Care, Platelet Aggregation Inhibitors, Primary Health Care, Prospective Studies, Pulmonary Circulation, Referral and Consultation, Prognosis, Registries, Renal Insufficiency, Research, Renin-Angiotensin System, Risk, Secondary Prevention, Sleep Apnea Syndromes, Stroke, Stroke Volume, Smoking Cessation, Surgeons, Systole, Taxus, Thoracic Surgery, Transcatheter Aortic Valve Replacement, Ventricular Dysfunction, Ticlopidine, Ventricular Function, Left

< Back to Listings